Preparing for Comparative Effectiveness Research

October 2009
HealthLeaders Magazine;Oct2009, Vol. 12 Issue 10, p47
The article highlights the independently-funded comparative effectiveness research (CER) which received an allocation amounted to 1.1 billion U.S. dollars from the 787 billion U.S. dollars worth of government stimulus package in the U.S. It is reportedly known as an offshoot of evidence-based medicine (EBM) and will fund research to improve patient care, eliminate waste, and improve standardization of supplies and devices. Contrary to EBM where conclusions are reached through field evidence, CER will draw conclusions from scientific research.


Related Articles

  • Researchers Putting Medicine Under the Microscope. Chambers, Heather // San Diego Business Journal;7/20/2009, Vol. 30 Issue 29, p23 

    The article reports on the comparative effectiveness research or studies that draw conclusions about the effectiveness of one drug, procedure or medical technique over another included in the economic stimulus package in the U.S. It states that consumer advocacy groups, labor unions and large...

  • SCIENCE.  // Enterprise/Salt Lake City;10/12/2009, Vol. 39 Issue 16, p17 

    The article reports that two researchers at the University of Utah Brain Institute have received a 923,787 U.S. dollars Challenge Grant in federal economics stimulus fund to research and create new ways of evaluating drugs for seizure disorder called temporal lobe epilepsy (TLE). About three...

  • (HEALTH) ARRA Offers New, Continuing Funds.  // Children & Youth Funding Report;2/5/2010, p13 

    The article reports on several competitions for funding for healthcare-related research with deadline in March 2010 offered by the American Recovery and Reinvestment Act of 2009 (ARRA) in the U.S. ARRA offers the Prevention Research Centers Comparative Effectiveness Research Program which worth...

  • Stimulus Bill Dedicates $1.1B to Comparing Treatment Options. Chambers, Heather // San Diego Business Journal;7/20/2009, Vol. 30 Issue 29, p23 

    The article reports on the allocation of 1.1 billion U.S. dollars for the so-called comparative effectiveness research to compare treatment options in the economic stimulus package in the U.S. According to proponents, head-to-head studies comparing one treatment over another has potential for...

  • Stem cell go ahead comes at the perfect moment.  // New Scientist;3/14/2009, Vol. 201 Issue 2699, p6 

    The article reports on the decision of U.S. President Barack Obama to lift George W. Bush's restrictions on the federal funding of research on human embryonic stem cells (ESCs). The move comes as the National Institutes of Health (NIH) prepares for an unprecedented windfall of $10.4 billion as...

  • Funding of cost-effectiveness studies could cause controversy.  // PharmacoEconomics & Outcomes News;4/18/2009, Issue 576, p2 

    The article focuses on the suggestion of Raynard Kington, acting director of the U.S. National Institute of Health (NIH), to finance studies on the cost effectiveness of medical treatments under the American Recovery and Reinvestment Act (ARRA). Kington proposed a $10.4 billion allocation for...

  • CER: Follow the Science. Benjamin, Marian // RT: The Journal for Respiratory Care Practitioners;Sep2009, Vol. 22 Issue 9, p10 

    The author reflects on the funds received by the comparative effectiveness research (CER) as part of the American Recovery and Reinvestment Act of 2009 (ARRA) in the U.S. She argues that CER is not without controversies, especially with the fear that the research will end up being...

  • (GRANTS) NIH Receives 20,000 Applications for Challenge Grants Through the Recovery Act.  // Aging News Alert;6/12/2009, p3 

    The article reports that the U.S. National Institutes of Health has received some 20,000 applications for Challenge Grants, a new program under the American Recovery and Reinvestment Act (ARRA). The program is designed to spur new areas of research and trigger an influx of research dollars into...

  • CONGRESS APPROVES NIST RECOVERY PLAN.  // Quality;Jul2009, Vol. 48 Issue 7, p10 

    The article reports on the approval of the budget for the Recovery Plan of the National Institute of Standards and Technology (NIST) of the U.S. Department of Commerce. Under the American Recovery and Reinvestment Act (ARRA), the institute will receive $580 million in direct appropriations and...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics